BridgeBio Oncology Therapeutics (BBOT)
Chamaine Centers currently serves as the Associate Director of Clinical Outsourcing at BBOT since June 2025. Prior to this role, Chamaine held the position of Associate Director of Clinical Business Operations at Relay Therapeutics from September 2024 to July 2025, and served as Senior Manager and then Manager of Clinical Outsourcing at Agios Pharmaceuticals between December 2022 and September 2024. Chamaine's experience also includes a managerial role at Denali Therapeutics, focusing on Clinical Outsourcing and Business Operations, and various positions in financial analysis at Lightship. Additionally, Chamaine started a career at Medpace with several roles in account management and business analysis, following an internship at Home Health Options Group. Chamaine holds a Bachelor of Science in Business Administration with a focus on Pharmaceutical Business from Ohio Northern University, completed in 2015.
This person is not in any teams
This person is not in any offices
BridgeBio Oncology Therapeutics (BBOT)
BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio, BridgeBio Oncology Therapeutics completed a $200M private financing with external investors in 2024 with the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors.